| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.00026 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0002 | 1 |